(Q44304000)

1 December 2017

ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells (English)

1 reference

1 December 2017

Ming-Shyue Lee

1

1 reference

1 December 2017

Ming-Shyue Lee

2

1 reference

1 December 2017

Tsukasa Igawa

3

1 reference

1 December 2017

Ta-Chun Yuan

4

1 reference

1 December 2017

Xiu-Qing Zhang

5

1 reference

1 December 2017

Fen-Fen Lin

6

1 reference

1 December 2017

Ming-Fong Lin

7

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

1 December 2017

1 reference

1 December 2017

22

1 reference

1 December 2017

781-796

1 reference

1 December 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1206066

1 December 2017

0 references

cites work

Endocrine treatment in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

Regulation of prostatic acid phosphatase expression and secretion by androgen in LNCaP human prostate carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

Prostate cancer: molecular biology of early progression to androgen independence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

Ligand and p185c-neu density govern receptor interactions and tyrosine kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

Her-2-neu expression and progression toward androgen independence in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

Prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

Studies on the human prostatic cancer cell line LNCaP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

Characterization of a prostate-specific tyrosine phosphatase by mutagenesis and expression in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

Management of advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Modulation of cytokeratin subtype, EGF receptor, and androgen receptor expression during progression of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

ErbB kinases and NDF signaling in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Overexpression of her-2/neu in human prostate cancer and benign hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Expression of the c-erbB-2 protein in normal and transformed cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Aberrant expression of the c-erbB-2/neu protooncogene in ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

R-Ras3/M-Ras induces neuronal differentiation of PC12 cells through cell-type-specific activation of the mitogen-activated protein kinase cascade.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Tyrosine kinase inhibition: an approach to drug development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

The cellular level of prostatic acid phosphatase and the growth of human prostate carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Differential responsiveness of prostatic acid phosphatase and prostate-specific antigen mRNA to androgen in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Decreased expression of cellular prostatic acid phosphatase increases tumorigenicity of human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Tyrosine phosphorylation of a 185 kDa phosphoprotein (pp185) inversely correlates with the cellular activity of human prostatic acid phosphatase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Expression of prostatic acid phosphatase in human prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Fluorescence in situ hybridization study of HER-2/neu oncogene amplification in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Antiproliferative activity of casodex (ICI 176.334) in hormone-dependent tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

c-erbB-2 oncoprotein expression in primary human tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Tyrosine phosphorylation of c-ErbB-2 is regulated by the cellular form of prostatic acid phosphatase in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Activation of the human androgen receptor through a protein kinase A signaling pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Hormone resistance in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Domain-specific Interactions between the p185neuand Epidermal Growth Factor Receptor Kinases Determine Differential Signaling Outcomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Gene expression and prostate specificity of human prostatic acid phosphatase (PAP): evaluation by RNA blot analyses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Prostate antigen: A new potential marker for prostatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Cloning and analysis of the promoter activity of the human prostatic acid phosphatase gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206066

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1206066

1 reference

Dimensions Publication ID

1 December 2017

0 references

1 reference